IBB/SPY ratio shows fantastic base in IBB/SPY from 2001 to 2012 ("bigger the base, the higher in space") with a huge breakout in early 2012 to recent highs in March 2015. But (and there's always a but), IBB/SPY exceeded channel (highlighted) last month and shows bearish negative divergence. Biotechs have been the "it" sector/niche in this bull market...now that it's showing weakness, what does that portend for greater market?
Good time to take profits in biotechs and go short?
Good time to take profits in biotechs and go short?